| COMVX | RYCDX | COMVX / RYCDX | |
| Total Expense Ratio | 0.00 | 2.63 | - |
| Annual Report Gross Expense Ratio | 3.15 | 2.73 | 115% |
| Fund Existence | 18 years | 25 years | - |
| Gain YTD | 3.386 | -22.560 | -15% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | 250 | 1000 | 25% |
| Net Assets | 11M | 11.3M | 97% |
| Annual Yield % from dividends | 1.89 | 19.89 | 10% |
| Returns for 1 year | 6.61 | -34.07 | -19% |
| Returns for 3 years | 25.32 | -74.79 | -34% |
| Returns for 5 years | 32.15 | -83.55 | -38% |
| Returns for 10 years | -29.61 | -99.28 | 30% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSVZX | 47.31 | 0.32 | +0.68% |
| Columbia Select Large Cap Value Inst | |||
| SMDIX | 22.26 | 0.06 | +0.27% |
| Hartford Schroders US MidCap Opps I | |||
| RPTIX | 98.95 | -0.16 | -0.16% |
| T. Rowe Price Mid-Cap Growth I | |||
| JMNSX | 15.25 | -0.03 | -0.20% |
| JPMorgan Research Market Neutral I | |||
| MELIX | 17.49 | -0.32 | -1.80% |
| Morgan Stanley Inst EMkts Ldrs I | |||